Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TR987 in Venous Leg Ulcers
NCT06707090Phase 3Recruiting
- Sponsor
- TR Therapeutics
- Start
- Jan 2025
- Primary completion
- Dec 2027
- Modality
- Polysaccharide, Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of TR-987 in venous leg ulcer (VLU), sponsored by TR Therapeutics. Started Jan 2025; status: recruiting.
02
Drugs
TR-987
03
Conditions
venous leg ulcer (VLU)
Beyond the preview
Go deeper on NCT06707090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06707090.